RECOMBINANT MVA VINTS AS POTENTIAL VACCINES AGAINST MALARIA BY P. FALCIPARUM.

摘要

Vaccine comprising a) a recombinant MVA virus, comprising a fragment or fragments of the nucleic acid encoding the Plasmodium falciparum MSP-1 protein; and b) a pharmacologically acceptable carrier, wherein the MSP-1 fragment or MSP-1 fragments encoded by the nucleic acid is chosen exclusively from: - p42; - p42 and p38; - p83, p30, p42 and p38.